Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus

SOUTH EASTON, Mass., Dec. 1 -- Pressure BioSciences, Inc. (Nasdaq: PBIO - News; "PBI" or the "Company") today announced a comprehensive restructuring program designed to significantly reduce costs, centralize core operations, and refocus the Company's business strategy in specific areas where the Company's products have found significant market acceptance. The restructuring program includes: -- a [...]

Fluidigm Secures Licenses to Key Inventions for Detecting Fetal Genetic Characteristics in Maternal Plasma

Fluidigm Corporation today announced that it has secured co-exclusive licenses to Stanford University inventions that detect fetal genetic characteristics in maternal plasma, including the use of a combination of digital PCR* and high-throughput sequencing. These licenses specifically cover a technique announced by a group of Stanford researchers several months ago that counted chromosomes by finding [...]

METTLER TOLEDO and Porter Lee Corporation Introduce BEAST LabX Interface

METTLER TOLEDO and Porter Lee Corporation announce an integrated solution that will improve workflow and the transfer of weight data in crime and forensics laboratories. LabX Balance Software combined with BEAST, a Laboratory Information Management System (LIMS) and Evidence Management System (EMS), creates a unique solution that provides crime and forensic lab analysts the means [...]

Finesse Announces TruDO Optical autoclavable sensors for Bioprocess Applications

Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the introduction of an autoclavable optical dissolved oxygen sensor that gives better performance and requires less maintenance than traditional DO sensors currently used in the industry. “Our new TruDO Optical sensor ushers in next-generation sensor technologies [...]

Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen

Affymetrix Inc., (Nasdaq:AFFX) announced today that scientists at Cancer Research UK have used Affymetrix technology to discover the molecular basis for tamoxifen response in breast cancer cells - and the reason why some women can develop resistance to the treatment. Their findings are published in Nature1. Tamoxifen is given to most women for five years [...]

Ocean Optics Acquires Oerlikon Optics USA Operation

Agreement is reached on the thin film supplier’s North American operation in Golden, Colorado Dunedin, FL (December 1, 2008) – Optical sensing pioneer Ocean Optics, Inc. has acquired the Oerlikon Optics business unit in Golden, Colo. Under terms of the agreement, Oerlikon will be fully integrated into Ocean Optics’ Thin Films Division. Oerlikon Optics USA [...]

New generation particle sizing analyzer from HEL

Collaboration with AstraZeneca leads to a new generation particle sizing analyzer from HEL For over 15 years HEL have been supplying their unique laboratory automation tools to AstraZeneca. This relationship has led to many projects, the latest of which was the development of the SAS solids particle analyzer. AstraZeneca had been using the Fisher Sub [...]

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PARIS, November 28 -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, [...]

PerkinElmer Names Achim von Leoprechting as Vice President, Cellular Imaging and Analysis

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the appointment of Achim von Leoprechting, Ph.D., as vice president and general manager, cellular imaging and analysis solutions. In this role, Dr.von Leoprechting will be responsible for driving the cellular imaging business for PerkinElmer. Dr. von Leoprechting [...]

State of Illinois Selects Tepnel’s Cystic Fibrosis Test for Mandated Screening of all Newborns

Tepnel Life Sciences plc ('Tepnel' or 'the Company') Manchester, UK, 26 November, 2008 -- Tepnel Life Sciences PLC (AIM: TED) today announced that the Illinois Department of Public Health has selected its Elucigene™ CF-US test for two-stage testing for cystic fibrosis (CF) as part of a new mandate to screen all newborns for the disease. [...]

Access IBO on Knowledge Center